Lupin launches generic chronic constipation treatment drug in US

Mumbai-based Lupin Ltd has introduced its generic Prucalopride tablets in the United States. This launch follows approval from the US health regulatory body. The tablets, available in 1 mg and 2 mg strengths, treat chronic idiopathic constipation in adults. These tablets are bioequivalent to Takeda Pharmaceuticals' Motegrity tablets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wL2lOsr
via IFTTT